ICD-10-CM › E00-E89 › E08-E13 › E codes › E13
E13
Other specified diabetes mellitus
Not billableICD-10-CM diagnosis code.
This code exists but cannot be submitted on its own. It groups the more specific codes beneath it.
Submit one of these 9 more specific codes instead:
- E13.0 Other specified diabetes mellitus with hyperosmolarity (also a header)
- E13.1 Other specified diabetes mellitus with ketoacidosis (also a header)
- E13.2 Other specified diabetes mellitus with kidney complications (also a header)
- E13.3 Other specified diabetes mellitus with ophthalmic complications (also a header)
- E13.4 Other specified diabetes mellitus with neurological complications (also a header)
- E13.5 Other specified diabetes mellitus with circulatory complications (also a header)
- E13.6 Other specified diabetes mellitus with other specified complications (also a header)
- E13.8 Other specified diabetes mellitus with unspecified complications
- E13.9 Other specified diabetes mellitus without complications
What has happened to this code
Every change the publisher made, from 2012 to now. Entries marked draft are from the pre-implementation releases: ICD-10 took effect on 1 October 2015, so nothing before FY2016 was ever valid on a claim.
- FY2012 Added to the draft code set draft Other specified diabetes mellitus
Official coding rules
Published by CDC for FY2027. A rule attached to a category binds every code beneath it, so the rules inherited from this code's ancestors are shown with the code they come from.
This code
Excludes1 - never coded here
- diabetes (mellitus) due to autoimmune process (E10.-)
- diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
- diabetes mellitus due to underlying condition (E08.-)
- drug or chemical induced diabetes mellitus (E09.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- type 1 diabetes mellitus (E10.-)
Use additional code
- code to identify control using:
- injectable non-insulin antidiabetic drugs (Z79.85)
- insulin (Z79.4)
- oral antidiabetic drugs (Z79.84)
- oral hypoglycemic drugs (Z79.84)
Includes
- diabetes mellitus due to genetic defects of beta-cell function
- diabetes mellitus due to genetic defects in insulin action
- postpancreatectomy diabetes mellitus
- postprocedural diabetes mellitus
- secondary diabetes mellitus NEC